Prospective RCT Lidocaine & Levobupivacaine on Block Dynamics After Subparaneural Popliteal Sciatic Nerve Block

NCT04397484 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Musculoskeletal Diseases or Conditions

Interventions

DRUG: 0.5% Levobupivacaine
DRUG: 2% Xylocaine with adrenaline 1:200,000

Sponsor

Chinese University of Hong Kong